Recon: SEC, FTC investigating Aduhelm approval and marketing; Doctors and public health group mount campaign for Biden’s FDA pick
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy